June 24, 2024 – Medtronic plc will current a complete set of recent information on the American Diabetes Affiliation (ADA) 84e Scientific periods demonstrating the advantages of the MiniMed™ 780G system. New information exhibits how the system addresses hyperglycemia and nocturnal burdens, including to the established physique of proof demonstrating the system's capability to deal with the distinctive and troublesome challenges of diabetes, akin to dealing with highs and meal administration or counting of carbohydrates, whereas additionally reflecting outcomes inside a broad affected person inhabitants.
Along with proof on the presently out there MiniMed™ 780G system, extra information shall be introduced on the subsequent iteration of the system*, which goals to additional cut back diabetes administration burden via its design. The system is meant to be mixed with the Simplera Sync™ sensor, a disposable, all-in-one steady glucose monitor (CGM) designed to eradicate the necessity for over-taping.
Among the many burdens of dwelling with diabetes, hyperglycemia can usually be overshadowed by hypoglycemia. But within the US, solely 26% of individuals with diabetes obtain an HbA1c stage of <7.0%. Decreasing time spent with excessive blood sugars stays an essential unmet want as a result of it might probably result in critical well being issues that have an effect on a number of organs. For youngsters, extended highs can have adversarial results on reminiscence, IQ, govt functioning and studying.
Study extra